Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
Small Science
|
August 21, 2025
Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein-Positive Cell Sensitization and Photothermal Therapy
Ahmed Alsadig, Xuan Peng, Hugo Boutier, et al.
International Journal of Molecular Sciences
|
March 27, 2025
Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells
Liliana R Loureiro, Susan Pike, Melinda Wuest, et al.
Oncoimmunology
|
August 21, 2019
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
Alexandra Kegler, Stefanie Koristka, Ralf Bergmann, et al.
Cancers
|
May 13, 2023
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, et al.
Small Science
|
May 21, 2025
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended-Gate Field-Effect-Transistor Biosensors
Trang-Anh Nguyen-Le, Christin Neuber, Isli Cela, et al.
Scientific Reports
|
July 24, 2019
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
Justyna Jureczek, Ralf Bergmann, Nicole Berndt, et al.
Molecular Therapy. Advances
|
May 15, 2026
Epigenetic editing balances TCR suppression and persistence in CAR T cells
Pascal Y Schönberg, Ángela Muñoz-Ovalle, Haidy A Saleh, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
Nicola Mitwasi, Claudia Arndt, Liliana R Loureiro, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 20, 2024
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates
Manja Kubeil, Christin Neuber, Miriam Starke, et al.
Cancer Immunology, Immunotherapy : CII
|
August 16, 2019
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
Stefanie Koristka, Pauline Ziller-Walter, Ralf Bergmann, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
Small Science
|
August 21, 2025
Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein-Positive Cell Sensitization and Photothermal Therapy
Ahmed Alsadig, Xuan Peng, Hugo Boutier, et al.
International Journal of Molecular Sciences
|
March 27, 2025
Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells
Liliana R Loureiro, Susan Pike, Melinda Wuest, et al.
Oncoimmunology
|
August 21, 2019
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
Alexandra Kegler, Stefanie Koristka, Ralf Bergmann, et al.
Cancers
|
May 13, 2023
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, et al.
Small Science
|
May 21, 2025
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended-Gate Field-Effect-Transistor Biosensors
Trang-Anh Nguyen-Le, Christin Neuber, Isli Cela, et al.
Scientific Reports
|
July 24, 2019
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
Justyna Jureczek, Ralf Bergmann, Nicole Berndt, et al.
Molecular Therapy. Advances
|
May 15, 2026
Epigenetic editing balances TCR suppression and persistence in CAR T cells
Pascal Y Schönberg, Ángela Muñoz-Ovalle, Haidy A Saleh, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
Nicola Mitwasi, Claudia Arndt, Liliana R Loureiro, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 20, 2024
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates
Manja Kubeil, Christin Neuber, Miriam Starke, et al.
Cancer Immunology, Immunotherapy : CII
|
August 16, 2019
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
Stefanie Koristka, Pauline Ziller-Walter, Ralf Bergmann, et al.
Page
of 9